Join to View Full Profile
Cholesterol Treatment Center5355Cincinnati, OH 45227
Phone+1 859-653-3141
Fax+1 513-579-8832
Dr. Stein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of the WitwatersrandClass of 1970
Certifications & Licensure
IL State Medical License 2016 - 2026
OH State Medical License 1977 - 2026
American Board of Pathology Chemical Pathology
Publications & Presentations
PubMed
- 1 citationsLerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, cr...Frederick J Raal, Vimal Mehta, Meral Kayikcioglu, Dirk Blom, Preeti Gupta
The Lancet. Diabetes & Endocrinology. 2025-03-01 - 11 citationsReduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study.Christoph U Correll, Evan Stein, Christine Graham, Lauren DiPetrillo, Sarah Akerman
Schizophrenia Bulletin. 2023-03-15 - 2 citationsTargeting PCSK9 inhibitors to those who will benefit most.Traci A Turner, Evan A Stein
The Lancet. Diabetes & Endocrinology. 2022-05-01
Press Mentions
Regeneron Flashes ‘Great Advancement’ in the NEJM for That Other Cholesterol Drug Sitting at the FDAAugust 19th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
